Blue-Chip Stocks Versus Penny Stocks

Blue-Chip Stocks Versus Penny Stocks

The stocks of large and big enterprises are usually considered as Blue-chip stocks. In Poker, Blue chips are the most expensive chips; likewise, in a stock market, blue-chip stocks are the most valuable stocks in the market with the attitude of ‘buy it and forget it’ for at least five years to ten years. Blue chips stocks are the ones that generally have a market capitalization of over $10 billion on the stock exchanges. On the other hand, Penny stocks are the ones that are typically priced less than $1 with a low market capitalization varying between $50 million and $300 million.

Penny stocks are more volatile than Blue-chip stocks. It means that a Penny stock can witness a lot of variation in its price in a day’s trade. As there is a lot of sudden movement in the Penny stocks prices, many investors try to take advantage of this opportunity to make quick money. However, there is an equal chance of losing money while trading in Penny Stocks. Penny stock’ investors don’t hold these stocks for a longer duration.

In the case of the Blue-chip Stocks, the prices are more stable than Penny stocks, and there are hardly any sudden changes in the prices.  To earn a significant amount of return from these stocks, investors need to hold these stocks for a longer duration.

As penny stocks are very volatile stocks and they witness a lot of sudden movement in their prices, Penny stocks are considered riskier than Blue chip stocks. Further, Penny stocks have some exceptionally basic qualities, for example, low delivery in %, low liquidity, driven by manipulators and speculators and most suitable for days’ trading. Although these stocks are very risky, these can help investors in making quick cash. Some notable Penny stocks which are currently trading on ASX are –

  • BrainChip Holding Ltd (ASX: BRN)- it is traded at $0.088 with the market capitalization of around $98.69 million (as of February 01, 2019);
  • Fluence Corporation Ltd (ASX: FLC)- it is traded at $0.360 with the market capitalization of around $194.53 million (as of February 01, 2019);
  • LiveTiles Limited (ASX: LVT) it is traded at $0.390 with the market capitalization of around $212.17 million (as of February 01, 2019).

On the other hand, Blue chip companies are generally large multinational firms. Investors considered these stocks as more trustworthy and less risky. Blue-chip stocks are generally backed by large capital which helps the company to sustain even if they are incurring losses. Some examples of blue-chip stocks are RIO Tinto Limited (ASX: RIO), Woodside Petroleum Limited (ASX: WPL), BHP Group Limited (ASX: BHP), etc.

Although there are differences in the Blue-chip and Penny Stocks and they attract a different type of investors, but there is no guarantee that either of these stocks will provide a positive return to an investor. An investor should understand the differences between these types of stocks and should learn about the opportunities that these stocks can provide, in order to make a better return.


This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report